We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




US Panel Supports Cloning Only for Treating Disease

By Biotechdaily staff writers
Posted on 21 May 2002
A panel of scientists from the US National Academy of Sciences (Washington, DC, USA) has reported that it supports the cloning of embryos to treat disease but not the creation of clones to reproduce human beings, which it says is not safe and should be outlawed. More...
The panel was composed of 11 experts from leading US medical and educational centers who considered the scientific and medical aspects of human reproductive cloning.

While many experts are in favor of research or therapeutic cloning, very few are in favor of reproductive cloning, so the report did not come as a surprise. However, the report adds to the ongoing US controversy over cloning. The US Senate is about to consider new legislation to ban all forms of cloning, for any purpose whatever. The legislation is backed by US President Bush. The same position is also held by the US Conference of Catholic Bishops, which argues that creating and destroying embryos for research interferes with the sanctity of human life. Meanwhile, the Council on Bioethics, appointed by President Bush, has also been wrestling with the ethics of cloning. Although no members favor reproductive cloning, many disagree on therapeutic cloning.

In recommending a ban on reproductive cloning, the academy's panel noted that within five years the ban should be reviewed, to be reconsidered only if new findings indicate that the process is safe and there is broad national backing for reconsideration. Following testimony from three scientists who plan to attempt the cloning of a human being, the panel concluded that "no voluntary system that is established to restrict reproductive cloning is likely to be completely effective.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Multi-Chamber Washer-Disinfector
WD 390
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.